Cagrilintide (5mg) / GLP-1 S (5mg)

Description

A two-component co-formulation of cagrilintide and a GLP-1–class peptide supplied for controlled research environments. Suitable for studies exploring amylin-receptor–related and GLP-1–receptor signaling pathways in model systems.

Composition

• • • Cagrilintide: 5mg

    • GLP-1 S: 5 mg

    • Fill volume: 2 ml vial

    • Appearance: lyophilized powder in a sealed research vial

Research Focus (non-clinical)

Cagrilintide (5mg) / GLP-1 S (5mg)

• • • Combined pathway evaluation of amylin-receptor–related and GLP-1–receptor mechanisms in in-vitro or ex-vivo models

    • Assay development, including chromatographic separation of two co-formulated peptides and blend ratio characterization

    • Stability characterization of a two-analyte lyophilized blend under laboratory storage conditions

    • Method documentation for HPLC/LC-MS identity and purity assessments

Documentation

• • • COA pending — third-party verification in progress

Important Notice

• • • For research use only

    • Not for human consumption

    • Not intended to diagnose, treat, cure, or prevent any disease

Quality & Manufacturing

• • COA pending — third-party verification in progress

  • Lyophilized for transit stability; batch traceable

  • Tamper-evident seal; lot & test date on each vial